Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Theravance Biopharma (TBPH) Times Interest Earned (2016 - 2025)

Theravance Biopharma (TBPH) has disclosed Times Interest Earned for 10 consecutive years, with $34.38 as the latest value for Q4 2025.

  • Quarterly Times Interest Earned rose 340.32% to $34.38 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.46 through Dec 2025, up 92.06% year-over-year, with the annual reading at -$1.46 for FY2025, 92.06% up from the prior year.
  • Times Interest Earned for Q4 2025 was $34.38 at Theravance Biopharma, up from -$11.27 in the prior quarter.
  • The five-year high for Times Interest Earned was $34.38 in Q4 2025, with the low at -$45.29 in Q1 2023.
  • Average Times Interest Earned over 5 years is -$15.37, with a median of -$15.79 recorded in 2024.
  • The sharpest move saw Times Interest Earned crashed 973.81% in 2021, then surged 340.32% in 2025.
  • Over 5 years, Times Interest Earned stood at -$26.28 in 2021, then fell by 20.59% to -$31.69 in 2022, then surged by 68.4% to -$10.02 in 2023, then plummeted by 42.85% to -$14.31 in 2024, then surged by 340.32% to $34.38 in 2025.
  • According to Business Quant data, Times Interest Earned over the past three periods came in at $34.38, -$11.27, and -$4.11 for Q4 2025, Q3 2025, and Q2 2025 respectively.